Genentech · 12 hours ago
2026 Summer Intern – Department of Biological Chemistry
South San Francisco, CA
Internship
Onsite
Intern
$26/hr - $46/hr
Start in 2026 SummerGenentech is a leading biotechnology company that leverages cutting-edge technologies in phage and yeast display, biochemistry, and biophysics. They are seeking a Summer Intern in the Department of Biological Chemistry to learn and perform phage display technology, analyze data, and conduct biochemical and biophysical assays.
BiotechnologyLife ScienceManufacturing
Responsibilities
Learn and perform phage display technology
Apply the phage-display to whole cell panning
Analyzing Next Generation Sequencing data
Utilizing machine learning model for hits optimization
Perform biochemical and biophysical assays with the hits generated from phage display technology
Qualification
Required
Must be pursuing a Bachelor's Degree (enrolled student)
Must have attained a Bachelor's Degree (not currently enrolled in a graduate program)
Must be pursuing a Master's Degree (enrolled student)
Must have attained a Master's Degree
Must be pursuing a PhD (enrolled student)
Required Majors: Chemistry, or Biological Science
Foundational knowledge of molecular biology, biochemistry, and cell biology, OR
Basic chemistry through coursework or laboratory experience
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Basic knowledge on Python coding
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
Labiotech UG
2026-01-17
2026-01-16
Company data provided by crunchbase